Characterization of social behaviors and oxytocinergic neurons in the S-100β overexpressing mouse model of Down Syndrome

Behavioural Brain Research

Volumn 141, Issue 2, 2003, Pages 229-236

  Borella, Alice ^a   Sumangali, Reka ^a   Ko, Jacqueline ^a   Whitaker Azmitia, Patricia M ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Bed nucleus of the stria terminalis; Down Syndrome; Oxytocin; S 100 ; Social interactions

Indexed keywords

CD1 ANTIGEN; OXYTOCIN RECEPTOR; PROTEIN S100B;

ALERTNESS; ANIMAL BEHAVIOR; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ARTICLE; AWARENESS; BODY POSITION; CELL COUNT; CONTROLLED STUDY; DOWN SYNDROME; FEAR; GROOMING; IMMUNOCYTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REARING; SNIFFING; SOCIAL BEHAVIOR; SOCIALIZATION; STRIA TERMINALIS; SUPRAOPTIC NUCLEUS;

AGGRESSION; ANIMALS; DOWN SYNDROME; GROOMING; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; NERVE GROWTH FACTORS; NEURONS; OXYTOCIN; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; S100 PROTEINS; SEPTAL NUCLEI; SOCIAL BEHAVIOR; SOCIAL DOMINANCE;

EID: 0038756043     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(02)00373-X     Document Type: Article

References (44)

1. Allore R., O'Hanlon D., Price R., Neilson K., Willard H.F., Cox D.R.et al. Gene encoding the beta subunit of S100 protein is on chromosome 21: implications for Down syndrome. Science. 239:1988;1311-1313.
2. Broad K.D., Kendrick K.M., Sirinathsinghi D.J., Keverne E.B. Changes in oxytocin immunoreactivity and mRNA expression in the sheep brain during pregnancy, parturition and lactation and in response to oestrogen and progesterone. J. Neuroendocrinol. 5:1993;435-444.
3. Brown R.E., Hauschild M., Holman S.D., Hutchison J.B. Mate recognition by urine odors in the Mongolian gerbil. Behav. Neural. Biol. 49:1988;174-183.
4. Chapman R.S., Hesketh L.J. Behavioral phenotype of individuals with Down Syndrome. Mental. Retad. Dev. Disabil. Res. Rev. 6:2000;84-95.
5. Coe D.A., Matson J.L., Russell D.W., Slifer K.J., Capone G.T., Baglio C.et al. Behavior problems of children with Down syndrome and life events. J. Autism Dev. Disord. 29(2):1999;149-156.
6. Delville Y., De Vries G.J., Ferris C.F. Neural connections of the anterior hypothalamus and agonistic behavior in golden hamsters. Brain Behav. Evol. 55(2):2000;53-76.
7. Dreifuss J.J., Tribollet E., Dubois-Dauphin M., Raggenbass M. Receptors and neural effects of oxytocin in the rodent hypothalamus and preoptic region. Ciba Found. Symp. 168:1992;187-199.
8. Dykens E.M., Hodapp R.M., Evans D.W. Profiles and development of adaptive behavior in children with Down syndrome. Am. J. Ment. Retard. 98(5):1994;580-587.
9. Friend W.C., Clapoff S., Landry C., Becker L.E., O'Hanlon D., Allore R.J.et al. Cell-specific expression of high levels of human S100 beta in transgenic mouse brain is dependent on gene dosage. J. Neurosci. 12(11):1992;4337-4346.
10. Ganiban J., Barnett D., Cicchetti D. Negative reactivity and attachment: Down syndrome's contribution to the attachment-temperament debate. Dev. Psychopathol. 12(1):2000;1-21.
11. Geldmacher D.S., Lerner A.J., Voci J.M., Noelker E.A., Somple L.C., Whitehouse P.J. Treatment of functional decline in adults with Down syndrome using selective serotonin-reuptake inhibitor drugs. J. Geriatr. Psychiatry Neurol. 10(3):1997;99-104.
12. Griffin W.S., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J.et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 86(19):1989;7611-7615.
13. Hermes M.L., Buijs R.M., Masson-Prevet M., Pevet P. Oxytocinergic innervation of the brain of the garden dormouse. J. Comp. Neurol. 273:1988;252-262.
14. Insel T.R., Young L.J. The neurobiology of attachment. Nat. Rev. Neurosci. 2(2):2001;129-136.
15. Johnson A.E., Coirini H., McEwen B., Insel T.R. Testosterone modulates oxytocin binding in the hypothalamus of castrated male rats. Neuroendocrinology. 50(2):1989;199-203.
16. Kelly J., Swanson L.W. Additional forebrain regions projecting to the posterior pituitary: preoptic region, bed nucleus of the stria terminalis, and zona incerta. Brain Res. 197(1):1980;1-9.
17. Knutson B., Wolkowitz O.M., Cole S.W., Chan T., Moore E.A., Johnson R.C.et al. Selective alteration of personality and social behavior by serotonergic intervention. Am. J. Psychiatry. 155:1998;373-379.
18. Labudova O., Fang-Kircher S., Cairns N., Moenkemann H., Yeghiarzaryan K., Lubec G. Brain vasopressin levels in Down syndrome and Alzheimer's disease. Brain Res. 806(1):1998;55-59.
19. Liu J.P., Lauder J.M. S-100 beta and insulin-like growth factor-II differentially regulate growth of developing serotonin and dopamine neurons in vitro. J. Neurosci. Res. 33(2):1992;248-256.
20. Lore R., Flannelly K. Rat societies. Sci. Am. 236(5):1977;106-111.
21. Mathieson W., Taylor S.W., Marshall M., Neumann P. Strain and sex differences in the morphology of the medial preoptic nucleus of mice. J. Comp. Neurol. 428:2000;254-265.
22. Miczek K.A., Maxson S.C., Fish E.W., Faccidomo S. Aggressive behavioral phenotypes in mice. Behav. Brain Res. 125(1-2):2001;167-185.
23. Morelli M., Pinna A., Ruiu S., Del Zompo M. Induction of Fos-like-immunoreactivity in the central extended amygdala by antidepressant drugs. Synapse. 31(1):1999;1-4.
24. Moskowitz D.S., Pinard G., Zuroff D.C., Annable L., Young S.N. The effect of tryptophan on social interaction in everyday life: a placebo-controlled study. Neuropsychopharmacology. 25:2001;277-289.
25. Olivier B., Molewijk H.E., van der Heyden J.A., van Oorschot R., Ronken E., Mos J.et al. Ultrasonic vocalizations in rat pups: effects of serotonergic ligands. Neurosci. Biobehav. Rev. 23(2):1998;215-227.
26. Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates, 2nd ed. New York: Academic Press; 2001.
27. Pfaus J.G., Heeb M.M. Implications of immediate-early gene induction in the brain following sexual stimulation of female and male rodents. Brain Res. Bull. 44(4):1997;397-407.
28. Pueschel S.M., Myers B.A. Environmental and temperament assessments of children with Down's syndrome. J. Intellect Disabil. Res. 38(Pt 2):1994;195-202.
29. Raleigh M.J., McGuire M.T., Brammer G.L., Pollack D.B., Yuwiler A. Serotonergic mechanisms promote dominance acquisition in adult male vervet monkeys. Brain Res. 559:1991;181-190.
30. Risser D., Lubec G., Cairns N., Herrera-Marschitz M. Excitatory amino acids and monoamines in parahippocampal gyrus and frontal cortical pole of adults with Down syndrome. Life Sci. 60(15):1997;1231-1237.
31. Royston M.C., McKenzie J.E., Gentleman S.M., Sheng J.G., Mann D.M., Griffin W.S.et al. Overexpression of S-100β in Down's syndrome: correlation with patient age and with beta-amyloid deposition. Neuropathol. Appl. Neurobiol. 25:1999;387-393.
32. Seidl R., Kaehler S.T., Prast H., Singewald N., Cairns N., Gratzer M.et al. Serotonin (5-HT) in brains of adult patients with Down syndrome. J. Neural. Transm. 57(Suppl):1999;221-232.
33. Shi H., Bartness T.J. Catecholaminergic enzymes, vasopressin and oxytocin distribution in Siberian hamster brain. Brain Res. Bull. 53:2000;833-843.
34. Stein D.J., Stein M.B., Goodwin W., Kumar R., Hunter B. The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder. Psychopharmacology. 158(3):2001;267-272.
35. Uvnas-Moberg K. Antistress pattern induced by oxytocin. News Physiol. Sci. 13:1998;22-25.
36. Van de Kar L.D., Javed A., Zhang Y., Serres F., Raap D.K., Gray T.S. 5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells. J. Neurosci. 21(10):2001;3572-3579.
37. Vivian J.A., Miczek K.A. Diazepam and gepirone selectively attenuate either 20-32 or 32-64 kHz ultrasonic vocalizations during aggressive encounters. Psychopharmacology (Berl.). 112(1):1993;66-73.
38. Walker D.L., Davis M. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J. Neurosci. 17(23):1997;9375-9383.
39. Wang Z., Moody K., Newman J.D., Insel T.R. Vasopressin and oxytocin immunoreactive neurons and fibers in the forebrain of male and female common marmosets. Synapse. 27:1997;14-25.
40. Whitaker-Azmitia PM. Serotonin in brain development: role of the 5-HT1A receptor and S-100β. In: Kalverboer AF, Gramsbergen A, editors. Handbook of brain and behavior in human development. Dordrecht: Kluwer Academic Publishers; 2001.
41. 1a receptors and regulates development of serotonin neurons. Brain Res. 528:1990;155.
42. Winslow J.T., Hearn E.F., Ferguson J., Young L.J., Matzuk M.M., Insel T.R. Infant vocalization, adult aggression, and fear behavior of an oxytocin null mutant mouse. Horm. Behav. 37(2):2000;145-155.
43. Witt D.M., Winslow J.T., Insel T.R. Increased social interactions in rats following chronic, centrally infused oxytocin. Pharmacol. Biochem. Behav. 43(3):1992;855-861.
44. Young L.J. The neurobiology of social recognition, approach, and avoidance. Biol. Psychiatry. 51(1):2002;18-26.